XGEVA - 55513-730-01 - (denosumab)

Alphabetical Index


Drug Information of XGEVA

Product NDC: 55513-730
Proprietary Name: XGEVA
Non Proprietary Name: denosumab
Active Ingredient(s): 120    mg/1.7mL & nbsp;   denosumab
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of XGEVA

Product NDC: 55513-730
Labeler Name: Amgen Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA125320
Marketing Category: BLA
Start Marketing Date: 20101118

Package Information of XGEVA

Package NDC: 55513-730-01
Package Description: 1 VIAL, SINGLE-USE in 1 CARTON (55513-730-01) > 1.7 mL in 1 VIAL, SINGLE-USE

NDC Information of XGEVA

NDC Code 55513-730-01
Proprietary Name XGEVA
Package Description 1 VIAL, SINGLE-USE in 1 CARTON (55513-730-01) > 1.7 mL in 1 VIAL, SINGLE-USE
Product NDC 55513-730
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name denosumab
Dosage Form Name INJECTION
Route Name SUBCUTANEOUS
Start Marketing Date 20101118
Marketing Category Name BLA
Labeler Name Amgen Inc
Substance Name DENOSUMAB
Strength Number 120
Strength Unit mg/1.7mL
Pharmaceutical Classes

Complete Information of XGEVA


General Information